"Spexin improves adipose tissue inflammation and macrophage recruitment in obese mice". 2020

Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
Laboratorio de Neuroendocrinología, Instituto Multidisciplinario de Biología Celular (IMBICE, CICPBA-CONICET-UNLP), Calle 526, 10 y 11, La Plata 1900, Argentina; Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, 1900, Argentina.

Spexin (SPX) is a novel adipokine related to many metabolic effects, such as gastrointestinal movements, insulin and glucose homeostasis, lipid metabolism and energy balance. This study evaluates the role of SPX in the improvement of the metabolic and inflammatory profile in fructose-rich-diet obese mice. Adult Swiss mice were supplemented or not with fructose (20% in tap water, FRD and CTR, respectively) for 10 weeks. The last ten days, mice were treated or not with SPX (ip. 29 μg/Kg/day, FRD-SPX and CTR-SPX, respectively). A positive correlation was observed between body weight prior to treatment and weight loss after SPX challenge. Moreover, plasma and liver triglycerides and adipose tissue (AT) features (mass, adipocyte hypertrophy, mRNA of leptin) were improved. SPX also induced a reduction in epididymal AT (EAT) expression of TNFα, IL1β and IL6 and an improvement in IL10 and CD206. M1 macrophages in EAT, principally the Ly6C- populations (M1a and M1b), were decreased. Adipocytes from FRD-SPX mice induced less macrophage activation (IL6, mRNA and secretion) than FRD after overnight co-culture with the monocyte cell line (RAW264.7) in stimulated conditions (M1 activation, LPS 100 ng/mL). Finally, in vitro, monocytes pre-incubated with SPX and stimulated with LPS showed decreased inflammatory mRNA markers compared to monocytes with LPS alone. In conclusion, SPX decreased body weight and improved the metabolic profile and adipocyte hypertrophy. Inflammatory Ly6C- macrophages decreased, together with inflammatory marker expression. In vitro studies demonstrate that SPX induced a decrease in M1 macrophage polarization directly or through mature adipocytes.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
February 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
February 2017, Diabetes,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
September 2019, The Journal of nutritional biochemistry,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
November 2022, Physiology & behavior,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
July 2021, Clinical science (London, England : 1979),
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
September 2008, American journal of physiology. Endocrinology and metabolism,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
July 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
August 2020, Lipids in health and disease,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
February 2012, Diabetes,
Sabrina Eliana Gambaro, and María Guillermina Zubiría, and Alejandra Paula Giordano, and Andrea Estefanía Portales, and Ana Alzamendi, and Martín Rumbo, and Andrés Giovambattista
November 2023, Biochemical pharmacology,
Copied contents to your clipboard!